Impact of thiopurine dose in anti-tumor necrosis factor combination therapy on outcomes in inflammatory bowel disease
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Gastroenterology"
DOI: 10.20524/aog.2022.0766
Abstract: Background Combination therapy with thiopurines and anti-tumor necrosis factor (TNF) is superior to monotherapy in Crohn’s disease (CD) and ulcerative colitis (UC). The optimal dose of thiopurines in combination therapy remains unclear. We investigated the… read more here.
Keywords: thiopurine dose; thiopurine; combination therapy;